Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Convertible Debt (2018 - 2019)

Historic Convertible Debt for CorMedix (CRMD) over the last 4 years, with Q2 2019 value amounting to $6.7 million.

  • CorMedix's Convertible Debt changed N/A to $6.7 million in Q2 2019 from the same period last year, while for Jun 2019 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $6.1 million for FY2018, which is N/A changed from last year.
  • CorMedix's Convertible Debt amounted to $6.7 million in Q2 2019.
  • CorMedix's Convertible Debt's 5-year high stood at $6.7 million during Q2 2019, with a 5-year trough of $6.1 million in Q4 2018.